Tracking sugar levels in the blood is crucial for monitoring diabetic patients, but current methods to measure glucose require needles and repeated finger-pricks throughout the day.
Now patients may no longer need to use such unpleasant tests. Instead, they can rely on off-the-shelf noninvasive wearables that use AI-based sensors to detect low levels of blood sugar, known as hypoglycemia, by looking at a patient’s heart rate.
Currently, Continuous Glucose Monitors (CGM) for hypoglycemia detection measure glucose levels using an invasive sensor with a little needle, which sends alarms and data to a display device. In many cases, they require calibration twice a day with finger-prick blood glucose level tests.
The novel device, however, uses an AI model that performs personalized therapy to give accurate results to each individual patient, making it more effective and reliable than current approaches. The game-changing invention has the potential to ease the lives of millions of diabetic patients around the world by making the painful and annoying finger-prick tests a thing of the past.
